These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 32039570)

  • 1. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
    Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
    Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients.
    Monserrat Sanz J; Bohórquez C; Gómez AM; Movasat A; Pérez A; Ruíz L; Diaz D; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
    Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
    Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis synovial fluid shows enrichment of T-cells producing GMCSF which are polyfunctional for TNFα and IFNγ.
    Khullar A; Dhir V; Saikia B; Yadav AK; Leishangthem B; Prasad CB; Jayaprakash S; Jain S; Naidu GSRSNK; Sharma SK; Sharma A; Jain S
    Clin Exp Rheumatol; 2024 Jul; 42(7):1435-1441. PubMed ID: 38372731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate preferentially affects Tc1 and Tc17 subset of CD8 T lymphocytes.
    Sandhu A; Ahmad S; Kaur P; Bhatnagar A; Dhawan V; Dhir V
    Clin Rheumatol; 2019 Jan; 38(1):37-44. PubMed ID: 29464523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders.
    Ellingsen T; Hornung N; Møller BK; Poulsen JH; Stengaard-Pedersen K
    Ann Rheum Dis; 2007 Feb; 66(2):151-7. PubMed ID: 16905577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.
    Cribbs AP; Kennedy A; Penn H; Amjadi P; Green P; Read JE; Brennan F; Gregory B; Williams RO
    Arthritis Rheumatol; 2015 May; 67(5):1182-92. PubMed ID: 25604080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament.
    Monserrat J; Bohórquez C; Gómez Lahoz AM; Movasat A; Pérez A; Ruíz L; Díaz D; Chara L; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
    Cells; 2019 Aug; 8(8):. PubMed ID: 31405169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in IDO1
    Malik AE; Slauenwhite D; McAlpine SM; Hanly JG; Marshall JS; Issekutz TB
    Front Immunol; 2024; 15():1352251. PubMed ID: 38840915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of PD-1 and Tim-3 expression on CD4
    Koohini Z; Hossein-Nataj H; Mobini M; Hosseinian-Amiri A; Rafiei A; Asgarian-Omran H
    Clin Rheumatol; 2018 Aug; 37(8):2063-2071. PubMed ID: 29626269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide.
    Zhong W; Zhao L; Liu T; Jiang Z
    Sci Rep; 2017 Jan; 7():41143. PubMed ID: 28117352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.
    Picchianti Diamanti A; Rosado MM; Scarsella M; Germano V; Giorda E; Cascioli S; Laganà B; D'Amelio R; Carsetti R
    Clin Exp Immunol; 2014 Sep; 177(3):630-40. PubMed ID: 24773026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4.
    Rudwaleit M; Yin Z; Siegert S; Grolms M; Radbruch A; Braun J; Sieper J
    Ann Rheum Dis; 2000 Apr; 59(4):311-4. PubMed ID: 10733482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood PD-1+TFh and CTLA-4+CD4+ T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis.
    Aldridge J; Andersson K; Gjertsson I; Hultgård Ekwall AK; Hallström M; van Vollenhoven R; Lundell AC; Rudin A
    Rheumatology (Oxford); 2022 Mar; 61(3):1233-1242. PubMed ID: 34009274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of peripheral follicular helper T cells in rheumatoid arthritis].
    An LM; Li J; Ji LL; Li GT; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):951-957. PubMed ID: 27987496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy.
    Oliveira RD; Fontana V; Junta CM; Marques MM; Macedo C; Rassi DM; Passos GA; Donadi EA; Louzada-Junior P
    J Rheumatol; 2012 Aug; 39(8):1524-32. PubMed ID: 22753658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID.
    Kummer LYL; Fernández Blanco L; Kreher C; Bos A; Kuijper LH; Verstegen NJM; van de Sandt CE; Konijn VAL; Duurland MC; Menage C; Jorritsma T; Steenhuis M; Hagen RR; van den Dijssel J; de Jongh R; Ashhurst T; van Gils MJ; Garcia-Vallejo JJ; Claireaux M; Stalman EW; van Dam KPJ; Wieske L; Boekel L; Wolbink G; Tas SW; Rispens T; Kuijpers TW; Eftimov F; van Ham SM; Ten Brinke A;
    RMD Open; 2024 Oct; 10(4):. PubMed ID: 39375177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.